What is Medline, Inc. 's debt issuance costs?

Medline, Inc. (MDLN) reported debt issuance costs of $0 in Q4 2025.

How has Medline, Inc. 's debt issuance costs changed year-over-year?

Medline, Inc. 's debt issuance costs decreased by 100.0% year-over-year, from $3M to $0.

What does debt issuance costs mean?

Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.

Medline, Inc. MDLN Debt Issuance Costs

Debt Issuance Costs at other companies

CorMedixCRMD

$135K—

NovantaNOVT

$1.29M—

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$33.35B+17.5%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Medline, Inc. ’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's debt issuance costs?: Medline, Inc. (MDLN) reported debt issuance costs of $0 in Q4 2025.
How has Medline, Inc. 's debt issuance costs changed year-over-year?: Medline, Inc. 's debt issuance costs decreased by 100.0% year-over-year, from $3M to $0.
What does debt issuance costs mean?: Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.